Crescita Therapeutics Inc
TSX:CTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aarey Drugs and Pharmaceuticals Ltd
NSE:AAREYDRUGS
|
IN |
Crescita Therapeutics Inc
Selling, General & Administrative
Crescita Therapeutics Inc
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Crescita Therapeutics Inc
TSX:CTX
|
Selling, General & Administrative
-CA$10.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Selling, General & Administrative
-$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-2%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Selling, General & Administrative
-CA$105.4m
|
CAGR 3-Years
39%
|
CAGR 5-Years
31%
|
CAGR 10-Years
-25%
|
|
|
Cronos Group Inc
TSX:CRON
|
Selling, General & Administrative
-$70.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-46%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Selling, General & Administrative
-$46m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-98%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Selling, General & Administrative
-CA$124.1m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-30%
|
|
Crescita Therapeutics Inc
Glance View
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Mississauga, Ontario and currently employs 69 full-time employees. The company went IPO on 2016-03-07. The firm offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The firm operates through three segments: Commercial Skincare, Licensing and Royalties and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products in both the Canadian and international markets. The Licensing and Royalties segment engaged in licensing the intellectual property related to Pliaglis, MMPE and DuraPeel, on either an exclusive or non-exclusive basis. The Manufacturing and Services segment engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization (CDMO) infrastructure, and sales of product development services.
See Also
What is Crescita Therapeutics Inc's Selling, General & Administrative?
Selling, General & Administrative
-10.8m
CAD
Based on the financial report for Dec 31, 2025, Crescita Therapeutics Inc's Selling, General & Administrative amounts to -10.8m CAD.
What is Crescita Therapeutics Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-10%
Over the last year, the Selling, General & Administrative growth was 0%. The average annual Selling, General & Administrative growth rates for Crescita Therapeutics Inc have been -4% over the past three years , -10% over the past five years .
